{"DataElement":{"publicId":"5211075","version":"1","preferredName":"Colorectal Tumor Histologic Classification Type","preferredDefinition":"Text term to identify the kind of malignant neoplasm that affects the colon.","longName":"COLO_HX_CLASS_TYP","context":"BBRB","contextVersion":"1","DataElementConcept":{"publicId":"2190146","version":"1","preferredName":"Colorectal Tumor Histologic Classification","preferredDefinition":"information related to histologic classification of a colorectal tumor.","longName":"COLO_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206583","version":"1","preferredName":"Colorectal Neoplasm","preferredDefinition":"(ko-lo-REK-tul) Having to do with the colon or the rectum.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C13363:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal","conceptCode":"C13363","definition":"Relating to the colon and rectum, or to the entire large bowel.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-FAFA-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E6E2FE79-4945-747D-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-20","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-20","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5210975","version":"1","preferredName":"Colorectal Carcinoma Histologic Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"5210975v1.0","context":"BBRB","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"125","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other - specify","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-657A-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, undifferentiated (WHO code: 8020/3)","valueDescription":"Colon Undifferentiated Carcinoma","ValueMeaning":{"publicId":"5210977","version":"1","preferredName":"Colon Undifferentiated Carcinoma","longName":"5210977","preferredDefinition":"An invasive malignant epithelial tumor that arises from the colon.  There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Undifferentiated Carcinoma","conceptCode":"C7100","definition":"An invasive malignant epithelial tumor that arises from the colon.  There is no morphologic, immunophenotypic, or molecular biological evidence of glandular or squamous differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-6587-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-65A0-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, squamous cell (epidermoid)(WHO code 8070/3)","valueDescription":"Colon Squamous Cell Carcinoma","ValueMeaning":{"publicId":"5210979","version":"1","preferredName":"Colon Squamous Cell Carcinoma","longName":"5210979","preferredDefinition":"A very rare colon carcinoma characterized by the presence of a malignant squamous cell infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Squamous Cell Carcinoma","conceptCode":"C5490","definition":"A very rare colon carcinoma characterized by the presence of a malignant squamous cell infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-65AD-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-65C6-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, small cell (WHO code: 8041/3)","valueDescription":"Colon Small Cell Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"5210981","version":"1","preferredName":"Colon Small Cell Neuroendocrine Carcinoma","longName":"5210981","preferredDefinition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon.  It is characterized by the presence of malignant small cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Small Cell Neuroendocrine Carcinoma","conceptCode":"C6761","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation that arises from the colon.  It is characterized by the presence of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-65D3-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-65EC-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, signet ring cell (greater than 50% signet ring cell)(WHO code: 8490/3)","valueDescription":"Colorectal Signet Ring Cell Carcinoma","ValueMeaning":{"publicId":"5210983","version":"1","preferredName":"Colorectal Signet Ring Cell Carcinoma","longName":"5210983","preferredDefinition":"An invasive colorectal adenocarcinoma characterized by the presence of malignant glandular epithelial cells with prominent intracytoplasmic mucin resulting in the displacement of the nuclei.  The malignant glandular cells with intracytoplasmic mucin constitute more than 50% of the malignant cellular infiltrate.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colorectal Signet Ring Cell Carcinoma","conceptCode":"C43586","definition":"An invasive colorectal adenocarcinoma characterized by the presence of malignant glandular epithelial cells with prominent intracytoplasmic mucin resulting in the displacement of the nuclei.  The malignant glandular cells with intracytoplasmic mucin constitute more than 50% of the malignant cellular infiltrate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-65F9-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-6612-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, mucinous (colloid type)(greater than 50% mucinous carcinoma)(WHO code: 8430/3)","valueDescription":"Colon Mucinous Adenocarcinoma","ValueMeaning":{"publicId":"3088064","version":"1","preferredName":"Colon Mucinous Adenocarcinoma","longName":"3088064","preferredDefinition":"An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Mucinous Adenocarcinoma","conceptCode":"C7966","definition":"An invasive adenocarcinoma of the colon characterized by the presence of pools of extracellular mucin.  Malignant glandular epithelial cells are present in the mucin collections.  Mucin constitutes more than 50% of the lesion.","evsSource":"RADLEX_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E26B-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-6626-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, medullary (WHO code: 8510/3)","valueDescription":"Colon Medullary Carcinoma","ValueMeaning":{"publicId":"5210985","version":"1","preferredName":"Colon Medullary Carcinoma","longName":"5210985","preferredDefinition":"A rare, invasive colon adenocarcinoma characterized by the presence of sheets of malignant epithelial cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm.  It usually has a favorable prognosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Medullary Carcinoma","conceptCode":"C60641","definition":"A rare, invasive colon adenocarcinoma characterized by the presence of sheets of malignant epithelial cells with vesicular nuclei, prominent nucleoli, and abundant eosinophilic cytoplasm.  It usually has a favorable prognosis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-6634-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-664D-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, adenosquamous (Who code: 8560/3)","valueDescription":"Colon Adenosquamous Carcinoma","ValueMeaning":{"publicId":"5210987","version":"1","preferredName":"Colon Adenosquamous Carcinoma","longName":"5210987","preferredDefinition":"An unusual colon carcinoma characterized by the presence of glandular and squamous carcinomatous components.  The two carcinomatous components may be admixed within the tumor, or the two may appear separately in different areas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Adenosquamous Carcinoma","conceptCode":"C5491","definition":"An unusual colon carcinoma characterized by the presence of glandular and squamous carcinomatous components.  The two carcinomatous components may be admixed within the tumor, or the two may appear separately in different areas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-665A-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-6673-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Carcinoma of colon, NOS (WHO code: 8010/3)","valueDescription":"Colon Carcinoma","ValueMeaning":{"publicId":"3475567","version":"1","preferredName":"Colon Carcinoma","longName":"3475567","preferredDefinition":"A malignant tumor usually arising from the epithelium lining the large intestinal mucosa.  Colon carcinoma is one of the most common malignancies in both males and females, and is especially common in North America and Europe.  Grossly, most colon carcinomas are polypoid or ulcerating lesions. Microscopically, adenocarcinoma is the most frequently seen morphologic subtype.  Prognosis depends on the stage of the disease (depth of invasion, metastasis to regional/distal lymph nodes or other anatomic sites). -- 2004","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Carcinoma","conceptCode":"C4910","definition":"A malignant epithelial neoplasm that arises from the colon and invades through the muscularis mucosa into the submucosa.  The vast majority are adenocarcinomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C1E80FC9-B780-A009-E040-BB89AD430688","latestVersionIndicator":"Yes","beginDate":"2012-06-07","endDate":null,"createdBy":"LEUNGE","dateCreated":"2012-06-07","modifiedBy":"ONEDATA","dateModified":"2012-06-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-6687-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"},{"value":"Adenocarcinoma of colon (WHO code: 8140/3)","valueDescription":"Colon Adenocarcinoma","ValueMeaning":{"publicId":"3088065","version":"1","preferredName":"Colon Adenocarcinoma","longName":"3088065","preferredDefinition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well differentiated, moderately, and poorly differentiated.  Morphologic variants include the mucinous adenocarcinoma and signet-ring adenocarcinoma.  Lymphatic or hematogenous spread can occur early in the process and lead to systemic disease.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon Adenocarcinoma","conceptCode":"C4349","definition":"An adenocarcinoma arising from the colon.  It is more frequently seen in populations with a Western type diet and in patients with a history of chronic inflammatory bowel disease.  Signs and symptoms include intestinal bleeding, anemia, and change in bowel habits.  According to the degree of cellular differentiation, colonic adenocarcinomas are divided into well, moderately, and poorly differentiated.  Histologic variants include mucinous adenocarcinoma, signet ring cell carcinoma, medullary carcinoma, serrated adenocarcinoma, cribriform comedo-type adenocarcinoma, and micropapillary adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"86E18C0F-E290-9226-E040-BB89AD430EF0","latestVersionIndicator":"Yes","beginDate":"2010-05-18","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"2FC38AC6-669C-8225-E050-BB89AD430B1C","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"ONEDATA","dateModified":"2016-04-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2FC38AC6-6564-8225-E050-BB89AD430B1C","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2016-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5188870","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB","ClassificationSchemeItems":[{"publicId":"5405791","version":"1","longName":"BPV - Tumor Biospecimen Acquisition","context":"BBRB"},{"publicId":"6736420","version":"1","longName":"Colon Local Path Review","context":"BBRB"}]}],"AlternateNames":[{"name":"BBRB","type":"USED_BY","context":"BBRB"}],"ReferenceDocuments":[{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"BBRB"}],"origin":"BPV: Biospecimen Pre-analytical Variables (BPV) Program","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"2FC569C5-2463-FA0C-E050-BB89AD433722","latestVersionIndicator":"Yes","beginDate":"2016-04-05","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2016-04-05","modifiedBy":"HARTLEYG","dateModified":"2019-04-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}